CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

Organogenesis Holdings Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: 781-575-0775

CIK: 0001661181
State Location: MA
State of Inc.: DE

Nasdaq:ORGO

Form: 4

Filing Date: 20 Feb 2026
Report Date: 18 Feb 2026
Accepted: 20 Feb 2026 03:28 p.m.
Accession Number: 0002064832-26-000061

Act: None
File Number: None
Film Number: None

Documents

Primary Document: STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Accepted: 20 Feb 2026 03:28 p.m.

0002064832-26-000061-index-headers.html

Last Modified: 20 Feb 2026 03:28 p.m.

0002064832-26-000061-index.html

Last Modified: 20 Feb 2026 03:28 p.m.

0002064832-26-000061.txt

Last Modified: 20 Feb 2026 03:28 p.m.

Last Modified: 20 Feb 2026 03:28 p.m.